Hormone resistance in prostate cancer.
Pilat
M J
MJ
Department of Internal Medicine, University of Michigan, Ann Arbor, USA.
Kamradt
J M
JM
Pienta
K J
KJ
D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000502:physiology*; D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015870:Gene Expression; D006801:Humans; D008297:Male; D051379:Mice; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000473:pathology* / Q000532:radiotherapy; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D011944:Receptors, Androgen / Q000502:physiology; D016879:Salvage Therapy
D000726:Androgen Antagonists; D000728:Androgens; D011944:Receptors, Androgen